Genentech Backtracks In Synagis Dispute
Genentech Inc. has pulled a complaint against biotech competitor MedImmune Inc. which alleged that MedImmune's Synagis, used to stave off dangerous respiratory tract infections in infants, violated its patents....To view the full article, register now.
Already a subscriber? Click here to view full article